Intellectual Property

Sen. Carl Levin (D-MI) questions a witness during a hearing of the Permanent Subcommittee on Investigations of the Senate Homeland Security and Governmental Affairs Committee November 20, 2014 in Washington, DC (Photo by Win McNamee/Getty Images)
Caption
Sen. Carl Levin (D-MI) questions a witness during a hearing of the Permanent Subcommittee on Investigations of the Senate Homeland Security and Governmental Affairs Committee November 20, 2014 in Washington, DC (Photo by Win McNamee/Getty Images)
Commentary
casey_michel
casey_michel
Former Adjunct Fellow, Kleptocracy Initiative
7 Min Read
Researchers at the UW Medicine Retrovirology Research Lab at Harborview Medical Center work on samples from the Novavax phase 3 Covid-19 clinical vaccine trial on February 12, 2021 in Seattle, Washington
Caption
Researchers at the UW Medicine Retrovirology Research Lab at Harborview Medical Center work on samples from the Novavax phase 3 Covid-19 clinical vaccine trial on February 12, 2021 in Seattle, Washington
Commentary
Adam Mossoff
Adam Mossoff
Chair, Forum for Intellectual Property and Senior Fellow
1 Min Read
Researchers at the UW Medicine Retrovirology Lab at Harborview Medical Center work on samples from the Novavax phase 3 Covid-19 clinical vaccine trials on February 12, 2021 in Seattle, Washington. (Photo by Karen Ducey/Getty Images)
Caption
Researchers at the UW Medicine Retrovirology Lab at Harborview Medical Center work on samples from the Novavax phase 3 Covid-19 clinical vaccine trials on February 12, 2021 in Seattle, Washington. (Photo by Karen Ducey/Getty Images)
Commentary
Adam Mossoff
Adam Mossoff
Chair, Forum for Intellectual Property and Senior Fellow
3 Min Read
stay informed putin
Stay Informed.

Sign up for our newsletter and get the latest insights and analysis you won’t find anywhere else tailored to the topics that matter to you.